Oxaltor 50mg Injection
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Oxaliplatin (50mg)
Overview Oxaltor 50mg Injection
Colon and rectal cancer is treated with Onxal 50mg Injection, a medication that inhibits or reduces the proliferation of cancerous cells. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial, as improper use or overdosing can lead to severe adverse reactions. While benefits may take weeks or months to manifest, discontinue use only under medical guidance. Common side effects include nausea, tiredness, vomiting, and diarrhea. The injection can lower blood cell counts (red and white), increasing infection risk. Serious allergic reactions, indicated by symptoms like mouth sores, rash, itching, or breathing difficulties, necessitate immediate medical attention. Regular blood tests monitoring blood cell levels, cardiac function, liver health, and uric acid are essential. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, and all other medications, particularly those for infections, as drug interactions are possible. This medication is contraindicated during pregnancy and breastfeeding. Due to its potential impact on male fertility, sperm preservation should be discussed with your physician. Post-injection dizziness may impair driving ability.
Uses of Oxaltor 50mg Injection
Colorectal cancer
Major Benefits of Oxaltor 50mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
Common Side effects of Oxaltor 50mg Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Oxaltor 50mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Oxaltor 50mg Injection works:
OncoGen 50mg injection is a cancer therapeutic agent. Its mechanism involves disrupting the genetic structure (DNA and RNA) of malignant cells, thereby halting their proliferation and expansion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Oxaltor 50mg Injection may pose unknown safety risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Oxaltor 50mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician may prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Oxaltor 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Oxaltor 50mg Injection, a medication that can induce side effects. Oxaliplatin therapy similarly carries a heightened risk of dizziness, nausea, vomiting, and other neurological issues impacting ambulation, potentially compromising driving safety.
KidneyCAUTION
For individuals with severe kidney impairment, administering Oxaltor 50mg Injection requires careful consideration and potential dose modification. Guidance from a physician is essential. Data regarding Oxaltor 50mg Injection use in such patients is limited. No dosage alteration is advised for patients exhibiting mild or moderate kidney dysfunction.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Oxaltor 50mg Injection. Dosage modification of Oxaltor 50mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Oxaltor 50mg Injection :
Forgetting a dose of Oxaltor 50mg Injection? Seek your physician's advice.
Facts to Know About Oxaltor 50mg Injection
| Label | Value |
|---|---|
| Chemical Category | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Active Class | Platinum-based Anticancer Agents |
3,018 People bought this recently